An immediate improvement to treatment opportunities would be to offer systematically genetic testing for BRCA1/2 mutation to all HGSOC, although it has been reported that 20% of women with ovarian cancer in community hospital settings were referred for genetic testing (21). The gene discussed is BRCA1; the disease is ovarian carcinoma.